Medicine and Dentistry
COVID-19 Vaccine
77%
Side Effect
72%
COVID-19 Vaccination
70%
Messenger RNA
55%
Comorbidity
42%
Coronavirinae
42%
Cariprazine
35%
Severe Acute Respiratory Syndrome Coronavirus 2
35%
Sympathetic Blocking
35%
Central Nervous System
35%
Generalized Anxiety Disorder
35%
Major Depressive Episode
35%
Liver Injury
35%
Parasympatholytic
35%
Catatonic Schizophrenia
35%
Stupor
35%
Somatics
35%
Treatment-Resistant Schizophrenia
35%
Emotional Stress
35%
Disease Predisposition
35%
Medical Record
35%
Antipsychotic
29%
Cross Sectional Study
24%
COVID-19
24%
Compulsive Behavior
23%
Delusion
23%
Self-Diagnosis
21%
Anxiety Disorder
20%
Social Interaction
18%
Drug Dose Reduction
17%
Prodromal Symptom
17%
Catatonia
17%
Social Isolation
17%
Visual Analog Scale
14%
Virus Vector
14%
Prevalence
11%
Schizoid Personality Disorder
11%
Paranoid Personality Disorder
11%
Laboratory Test
11%
Mood Disorder
11%
Spectrum Disorder
11%
Meta-Analysis
11%
Negative Syndrome
11%
Nerve Block
11%
Clinical Study
11%
Emerging Treatment
11%
Stellate Ganglion Block
11%
Ropivacaine
11%
Positive Syndrome
11%
Autonomic Dysfunction
11%
Pharmacology, Toxicology and Pharmaceutical Science
Side Effect
100%
Major Depression
70%
COVID-19 Vaccine
52%
Messenger RNA
52%
Treatment-Resistant Schizophrenia
35%
Catatonic Schizophrenia
35%
Inflammatory Bowel Disease
35%
Viral Vector
35%
Cariprazine
35%
Disease Predisposition
35%
Stupor
35%
Cholinergic Receptor Blocking Agent
35%
Autonomic Dysfunction
35%
Tolerability
35%
Clinical Study
35%
Ropivacaine
35%
Antipsychotic
29%
Pandemic
23%
Typical Antipsychotic
17%
Catatonia
17%
Coronavirinae
17%
Comorbidity
17%
Prodromal Symptom
17%
Vaccination Reaction
17%
Leukocytosis
17%
Atypical Antipsychotics
17%
C Reactive Protein
17%
Clinical Feature
17%
Cross-Sectional Study
17%
Paranoid Personality Disorder
11%
Remission
11%
Positive Syndrome
11%
Negative Syndrome
11%
Polypharmacy
11%
Schizoidism
5%
Prevalence
5%
Olanzapine
5%
Nursing and Health Professions
Practice Guideline
70%
Hospital Readmission
70%
Cross-Sectional Study
44%
Hamilton Depression Rating Scale
35%
Inflammatory Bowel Disease
35%
Comorbidity
35%
Depressive Disorder
35%
Self Evaluation
31%
Visual Analog Scale
17%
Outpatient
15%
Patient with Inflammatory Bowel Disease
15%
Isoprenaline
11%
Clinical Practice
10%
Major Depression
10%
Nonparametric Test
8%
Confounding Factor
8%
Marital Status
8%
Quality of Life Assessment
8%
World Health Organization
8%
Crohn's Disease
5%
Ulcerative Colitis
5%
Outpatient Department
5%
Medical Documentation
5%
State Trait Anxiety Inventory
5%
